Advances in Therapeutic Drug Monitoring for Small-Molecule and Biologic Therapies in Inflammatory Bowel Disease

被引：32
|
作者：
Christopher Ma
Robert Battat
Vipul Jairath
Niels Vande Casteele
机构：
[1] University of Calgary,Division of Gastroenterology and Hepatology
[2] Robarts Clinical Trials,Division of Gastroenterology
[3] Inc.,Department of Medicine, Division of Gastroenterology
[4] University of California San Diego,Department of Epidemiology and Biostatistics
[5] Western University,Department of Medicine
[6] Western University,undefined
[7] University of California San Diego,undefined
来源：
Current Treatment Options in Gastroenterology | 2019年 / 17卷 / 1期
关键词：
Biologics; Crohn’s disease; Inflammatory bowel disease; Therapeutic drug monitoring; Thiopurines; Ulcerative colitis;
D O I：
10.1007/s11938-019-00222-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：127 / 145
页数：18
相关论文
共 50 条
  • [1] Therapeutic Drug Monitoring for Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease
    Dutt, Krishneel
    Vasudevan, Abhinav
    MEDICINA-LITHUANIA, 2024, 60 (02):
  • [2] Advances in Therapeutic Drug Monitoring in Biologic Therapies for Pediatric Inflammatory Bowel Disease
    Kapoor, Akshay
    Crowley, Eileen
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [3] Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel Disease
    Baumgart, Daniel C.
    Le Berre, Catherine
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (14): : 1302 - 1315
  • [4] Advances in Therapeutic Drug Monitoring of Biologic Therapies in Inflammatory Bowel Disease: 2015 in Review
    Frank I. Scott
    Gary R. Lichtenstein
    Current Treatment Options in Gastroenterology, 2016, 14 (1) : 91 - 102
  • [5] Proactive and Reactive Therapeutic Drug Monitoring of Biologic Therapies in Inflammatory Bowel Disease Are Complementary, Not Mutually Exclusive
    Steenholdt, Casper
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (04) : 597 - 598
  • [6] Second Mexican consensus on biologic therapy and small-molecule inhibitors in inflammatory bowel disease
    Yamamoto-Furusho, J. K.
    Bosques-Padilla, F. J.
    Martinez-Vazquez, M. A.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2021, 86 (01): : 70 - 85
  • [7] Proactive and Reactive Therapeutic Drug Monitoring of Biologic Therapies in Inflammatory Bowel Disease Are Complementary, Not Mutually Exclusive Reply
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    Osterman, Mark T.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (04) : 598 - 599
  • [8] Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies
    Kim, Duk Hwan
    Cheon, Jae Hee
    IMMUNE NETWORK, 2017, 17 (01) : 25 - 40
  • [9] Multi-Omics Biomarkers for Predicting Efficacy of Biologic and Small-Molecule Therapies in Adults With Inflammatory Bowel Disease: A Systematic Review
    Chen, Liru
    Zhang, Chuhan
    Niu, Ruixuan
    Xiong, Shanshan
    He, Jinshen
    Wang, Yu
    Zhang, Pingxin
    Su, Fengyuan
    Liu, Zishan
    Zhou, Longyuan
    Mao, Ren
    Hu, Shixian
    Chen, Minhu
    Qiu, Yun
    Feng, Rui
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2024,
  • [10] A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
    Vaughn, Byron P.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
12345